Comera Life Sciences Holdings- Warrants (19/05/2027) Common Stock

The latest common stock for CMRAW is $2.8K as of September 2023. That compares with $1.7K in the prior-year period — up 65.7% year over year. Investors often review this figure alongside Comera Life Sciences Holdings- Warrants (19/05/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CMRAW's common stock moved from $1.7K to $2.8K — a 65.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Comera Life Sciences Holdings- Warrants (19/05/2027)'s operating scale or balance-sheet position.

A common stock figure of $2.8K for CMRAW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CMRAW's common stock ($2.8K), review year-over-year change from $1.7K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.